Journal
DALTON TRANSACTIONS
Volume 40, Issue 14, Pages 3445-3454Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c0dt01743d
Keywords
-
Categories
Funding
- University of California, San Diego
- National Institutes of Health [R01 HL00049, R21 HL094571]
- American Heart Association [0970028 N]
- Center for AIDS Research
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL094571] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098435] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Numerous metalloproteins are important therapeutic targets that are gaining increased attention in the medicinal and bioinorganic chemistry communities. This Perspective article describes some emerging trends and recent findings in the area of metalloprotein inhibitor discovery and development. In particular, increasing recognition of the importance of the metal-ligand interactions in these systems calls for more input and consideration from the bioinorganic community to address questions traditionally confined to the medicinal chemistry community.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available